期刊文献+

吸烟与男性肠癌相关性的回顾性分析 被引量:2

A retrospective study of the correlation between smoking and male colorectal carcinogenesis by location
下载PDF
导出
摘要 目的研究吸烟与男性大肠癌人群发病部位的关联。方法收集我院2010~2016年的男性结直肠癌住院患者,按吸烟变量和发病部位分组,进行回顾性病例分析。结果右半结肠癌、直肠癌吸烟与不吸烟组在年龄构成上有差别(P<0.05);左半结肠癌便血更多见于非吸烟组(35.4%),腹痛更多见于吸烟组(33.0%)(P<0.05);吸烟组高中分化腺癌患者比例高于非吸烟组(P<0.05);在吸烟指数上,直肠癌重度吸烟者依次高于右半结肠癌、左半结肠癌患者相应比例(P<0.05)。结论吸烟和发病部位分别是影响大肠癌发病的独立因素,不同部位吸烟与不吸烟男性肠癌患者在肿瘤的诊断、临床病理学特征、预后等方面存在差异。 Objective To investigate the association between smoking and lesion sites of colorectal cancer in male patients.Methods Clinical data of male patients with colorectal cancer who were admitted into our hospital from2010to2016were collected and retrospectively analyzed.Patients were divided into smoking group and non-smoking group.Results There were significant differences in the age composition ratio between left-and right-sided colon cancer smoking and non-smoking group(P<0.05).More patients with left-sided colon cancer in non-smoking group suffered from hematochezia(35.4%),while abdominal pain seems more common in the smoking group(33.0%)(P<0.05).The proportion of patients with high differentiation adenocarcinoma in smoking group was higher than that in non-smoking group(P<0.05);when it comes to the smoking index,the proportion of heavy smokers in rectal cancer were higher than the right-and left-sided colon cancer patients(P<0.05).Conclusion Smoking and location are independent factors for colorectal cancer,different parts of colorectal cancer between smoking and non-smoking groups have differences in the diagnosis of sensitivity,clinical pathology and prognosis.
作者 王慧中 杨琼 李炜玉 谢德荣 江志敏 WANG Huizhong;YANG Qiong;LI Weiyu;XIE Derong;JIANG Zhimin(Department of Oncology,Sun Yat . sen Memorial Hospital,Sun Yat . sen University,Guangzhou 510120,China)
出处 《岭南现代临床外科》 2018年第1期52-56,共5页 Lingnan Modern Clinics in Surgery
关键词 吸烟 肠癌 部位 男性 smoking colorectal cancer location male
  • 相关文献

参考文献1

二级参考文献56

  • 1Xiang L, Zhan Q, Zhao XH, Wang YD, An SL, Xu YZ, Li AM,Gong W, Bai Y, Zhi FC, Liu SD. Risk factors associated withmissed colorectal flat adenoma: a multicenter retrospective tandemcolonoscopy study. World J Gastroenterol 2014; 20: 10927-10937#[PMID: 25152596 DOI: 10.3748/wjg.v20.i31.10927].
  • 2Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H.Comparison of 17,641 patients with right- and left-sided coloncancer: differences in epidemiology, perioperative course, histology,and survival. Dis Colon Rectum 2010; 53: 57-64 [PMID: 20010352DOI: 10.1007/DCR.0b013e3181c703a4].
  • 3Moritani K, Hasegawa H, Okabayashi K, Ishii Y, Endo T, KitagawaY. Difference in the recurrence rate between right- and left-sidedcolon cancer: a 17-year experience at a single institution. SurgToday 2014; 44: 1685-1691 [PMID: 24126535 DOI: 10.1007/s00595-013-0748-5].
  • 4Wiggers T, Arends JW, Volovics A. Regression analysis ofprognostic factors in colorectal cancer after curative resections. DisColon Rectum 1988; 31: 33-41 [PMID: 3366023].
  • 5Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N. Isthere a difference in survival between right- versus left-sided coloncancers- Ann Surg Oncol 2008; 15: 2388-2394 [PMID: 18622647DOI: 10.1245/s10434-008-0015-y].
  • 6Weiss JM, Schumacher J, Allen GO, Neuman H, Lange EO,Loconte NK, Greenberg CC, Smith MA. Adjuvant chemotherapyfor stage II right-sided and left-sided colon cancer: analysis ofSEER-medicare data. Ann Surg Oncol 2014; 21: 1781-1791 [PMID:24643898 DOI: 10.1245/s10434-014-3631-8].
  • 7Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, IacopettaB. Association of tumour site and sex with survival benefitfrom adjuvant chemotherapy in colorectal cancer. Lancet2000; 355: 1745-1750 [PMID: 10832824 DOI: 10.1016/s0140-6736(00)02261-3].
  • 8Missiaglia E, Jacobs B, D'Ario G, Di Narzo AF, Soneson C,Budinska E, Popovici V, Vecchione L, Gerster S, Yan P, Roth AD,Klingbiel D, Bosman FT, Delorenzi M, Tejpar S. Distal and proximalcolon cancers differ in terms of molecular, pathological, and clinicalfeatures. Ann Oncol 2014; 25: 1995-2001 [PMID: 25057166 DOI:10.1093/annonc/mdu275].
  • 9Sinicrope FA, Mahoney MR, Smyrk TC, Thibodeau SN, WarrenRS, Bertagnolli MM, Nelson GD, Goldberg RM, Sargent DJ, AlbertsSR. Prognostic impact of deficient DNA mismatch repair in patientswith stage III colon cancer from a randomized trial of FOLFOXbasedadjuvant chemotherapy. J Clin Oncol 2013; 31: 3664-3672[PMID: 24019539 DOI: 10.1200/jco.2013.48.9591].
  • 10Yoon HH, Tougeron D, Shi Q, Alberts SR, Mahoney MR, NelsonGD, Nair SG, Thibodeau SN, Goldberg RM, Sargent DJ, SinicropeFA. KRAS codon 12 and 13 mutations in relation to diseasefreesurvival in BRAF-wild-type stage III colon cancers from anadjuvant chemotherapy trial (N0147 alliance). Clin Cancer Res2014; 20: 3033-3043 [PMID: 24687927 DOI: 10.1158/1078-0432.ccr-13-3140].

共引文献35

同被引文献22

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部